innotrac的评价!第二代心肌肌钙蛋白I测定:主要特点为临床常规使用。

P Hedberg, J Valkama, E Suvanto, S Pikkujämsä, K Ylitalo, E Alasaarela, M Puukka
{"title":"innotrac的评价!第二代心肌肌钙蛋白I测定:主要特点为临床常规使用。","authors":"P Hedberg,&nbsp;J Valkama,&nbsp;E Suvanto,&nbsp;S Pikkujämsä,&nbsp;K Ylitalo,&nbsp;E Alasaarela,&nbsp;M Puukka","doi":"10.1155/JAMMC/2006/39325","DOIUrl":null,"url":null,"abstract":"<p><p>The availability of a simple, sensitive, and rapid test using whole blood to facilitate processing and to reduce the turnaround time could improve the management of patients presenting with chest pain. The aim of this study was an evaluation of the Innotrac Aio! second-generation cardiac troponin I (cTnI) assay. The Innotrac Aio! second-generation cTnI assay was compared with the Abbott AxSYM first-generation cTnI, Beckman Access AccuTnI, and Innotrac Aio! first-generation cTnI assays. We studied serum samples from 15 patients with positive rheumatoid factor but with no indication of myocardial infarction (MI). Additionally, the stability of the sample with different matrices and the influence of hemodialysis on the cTnI concentration were evaluated. Within-assay CVs were 3.2%-10.9%, and between-assay precision ranged from 4.0% to 17.2% for cTnI. The functional sensitivity (CV = 20 %) and the concentration giving CV of 10% were approximated to be 0.02 and 0.04, respectively. The assay was found to be linear within the tested range of 0.063-111.6 mu g/L. The correlations between the second-generation Innotrac Aio!, Access, and AxSYM cTnI assays were good (r coefficients 0.947-0.966), but involved differences in the measured concentrations, and the biases were highest with cTnI at low concentrations. The second-generation Innotrac Aio! cTnI assay was found to be superior to the first-generation assay with regard to precision in the low concentration range. The stability of the cTnI level was best in the serum, lithium-heparin plasma, and lithium-heparin whole blood samples (n = 10 , decrease < 10 % in 24 hours at +20( degrees )C and at +4( degrees )C. There was no remarkable influence of hemodialysis on the cTnI release. False-positive cTnI values occurred in the presence of very high rheumatoid factor values, that is, over 3000 U/L. The 99th percentile of the apparently healthy reference group was </= 0.03 mu g/L. The results demonstrate the very good analytical performance of the second-generation Innotrac Aio! cTnI assay.</p>","PeriodicalId":15248,"journal":{"name":"Journal of Automated Methods & Management in Chemistry","volume":"2006 ","pages":"39325"},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/JAMMC/2006/39325","citationCount":"19","resultStr":"{\"title\":\"Evaluation of innotrac aio! Second-generation cardiac troponin I assay: the main characteristics for routine clinical use.\",\"authors\":\"P Hedberg,&nbsp;J Valkama,&nbsp;E Suvanto,&nbsp;S Pikkujämsä,&nbsp;K Ylitalo,&nbsp;E Alasaarela,&nbsp;M Puukka\",\"doi\":\"10.1155/JAMMC/2006/39325\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The availability of a simple, sensitive, and rapid test using whole blood to facilitate processing and to reduce the turnaround time could improve the management of patients presenting with chest pain. The aim of this study was an evaluation of the Innotrac Aio! second-generation cardiac troponin I (cTnI) assay. The Innotrac Aio! second-generation cTnI assay was compared with the Abbott AxSYM first-generation cTnI, Beckman Access AccuTnI, and Innotrac Aio! first-generation cTnI assays. We studied serum samples from 15 patients with positive rheumatoid factor but with no indication of myocardial infarction (MI). Additionally, the stability of the sample with different matrices and the influence of hemodialysis on the cTnI concentration were evaluated. Within-assay CVs were 3.2%-10.9%, and between-assay precision ranged from 4.0% to 17.2% for cTnI. The functional sensitivity (CV = 20 %) and the concentration giving CV of 10% were approximated to be 0.02 and 0.04, respectively. The assay was found to be linear within the tested range of 0.063-111.6 mu g/L. The correlations between the second-generation Innotrac Aio!, Access, and AxSYM cTnI assays were good (r coefficients 0.947-0.966), but involved differences in the measured concentrations, and the biases were highest with cTnI at low concentrations. The second-generation Innotrac Aio! cTnI assay was found to be superior to the first-generation assay with regard to precision in the low concentration range. The stability of the cTnI level was best in the serum, lithium-heparin plasma, and lithium-heparin whole blood samples (n = 10 , decrease < 10 % in 24 hours at +20( degrees )C and at +4( degrees )C. There was no remarkable influence of hemodialysis on the cTnI release. False-positive cTnI values occurred in the presence of very high rheumatoid factor values, that is, over 3000 U/L. The 99th percentile of the apparently healthy reference group was </= 0.03 mu g/L. The results demonstrate the very good analytical performance of the second-generation Innotrac Aio! cTnI assay.</p>\",\"PeriodicalId\":15248,\"journal\":{\"name\":\"Journal of Automated Methods & Management in Chemistry\",\"volume\":\"2006 \",\"pages\":\"39325\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/JAMMC/2006/39325\",\"citationCount\":\"19\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Automated Methods & Management in Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/JAMMC/2006/39325\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Automated Methods & Management in Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/JAMMC/2006/39325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

摘要

一种使用全血的简单、灵敏、快速的检测方法的可用性,可以促进处理并减少周转时间,从而改善胸痛患者的管理。本研究的目的是评估Innotrac Aio!第二代心肌肌钙蛋白I (cTnI)测定。Innotrac Aio!第二代cTnI检测与雅培AxSYM第一代cTnI、Beckman Access AccuTnI和Innotrac Aio比较。第一代cTnI检测。我们研究了15例类风湿因子阳性但无心肌梗死(MI)迹象的患者的血清样本。此外,还评估了不同基质样品的稳定性以及血液透析对cTnI浓度的影响。cTnI的测定内CVs为3.2%-10.9%,测定间精密度为4.0% - 17.2%。功能灵敏度(CV = 20%)和浓度(CV = 10%)分别近似为0.02和0.04。在0.063 ~ 111.6 μ g/L的检测范围内呈线性。第二代Innotrac Aio!、Access和AxSYM的cTnI检测效果良好(r系数0.947-0.966),但涉及到测量浓度的差异,低浓度的cTnI偏差最大。第二代Innotrac Aio!发现cTnI测定法在低浓度范围内的精度优于第一代测定法。血清、锂-肝素血浆和锂-肝素全血样品中cTnI水平的稳定性最好(n = 10),在+20(℃)和+4(℃)时24小时下降< 10%。血液透析对cTnI释放无显著影响。假阳性的cTnI值发生在类风湿因子值非常高的情况下,即超过3000 U/L。表面健康参照组的第99百分位数为
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of innotrac aio! Second-generation cardiac troponin I assay: the main characteristics for routine clinical use.

The availability of a simple, sensitive, and rapid test using whole blood to facilitate processing and to reduce the turnaround time could improve the management of patients presenting with chest pain. The aim of this study was an evaluation of the Innotrac Aio! second-generation cardiac troponin I (cTnI) assay. The Innotrac Aio! second-generation cTnI assay was compared with the Abbott AxSYM first-generation cTnI, Beckman Access AccuTnI, and Innotrac Aio! first-generation cTnI assays. We studied serum samples from 15 patients with positive rheumatoid factor but with no indication of myocardial infarction (MI). Additionally, the stability of the sample with different matrices and the influence of hemodialysis on the cTnI concentration were evaluated. Within-assay CVs were 3.2%-10.9%, and between-assay precision ranged from 4.0% to 17.2% for cTnI. The functional sensitivity (CV = 20 %) and the concentration giving CV of 10% were approximated to be 0.02 and 0.04, respectively. The assay was found to be linear within the tested range of 0.063-111.6 mu g/L. The correlations between the second-generation Innotrac Aio!, Access, and AxSYM cTnI assays were good (r coefficients 0.947-0.966), but involved differences in the measured concentrations, and the biases were highest with cTnI at low concentrations. The second-generation Innotrac Aio! cTnI assay was found to be superior to the first-generation assay with regard to precision in the low concentration range. The stability of the cTnI level was best in the serum, lithium-heparin plasma, and lithium-heparin whole blood samples (n = 10 , decrease < 10 % in 24 hours at +20( degrees )C and at +4( degrees )C. There was no remarkable influence of hemodialysis on the cTnI release. False-positive cTnI values occurred in the presence of very high rheumatoid factor values, that is, over 3000 U/L. The 99th percentile of the apparently healthy reference group was

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
>12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信